• Delegation from the Hong Kong Polytechnic University visits ShanghaiTech
    On the afternoon of April 12, Teng Jin-Guang, President of the Hong Kong Polytechnic University (PolyU), visited ShanghaiTech University. Jiang Mianheng, President of ShanghaiTech University, met with the delegation led by President Teng.President Jiang extended a warm welcome to the PolyU delegation at the meeting. Following the introduction of each university’s vision, mission and general infor...
    2024-04-19
  • World record for perovskite solar cells efficiency by new passivation strategy
    Halide perovskite solar cells are currently deemed as the most promising third-generation photovoltaic technology, opening vast opportunities for transformative development in the solar cell industry. In recent years, the efficiency of halide perovskite cells has been constantly improved, however, there remains a gap compared to the theoretical limits. Therefore, enhancing the efficiency of perovs...
    2024-04-19
  • Programmable and parallel 3D nanoprinting using configured electric fields
    Under the guidance of Assistant Professor Feng Jicheng in the School of Physical Science and Technology (SPST), a research team has recently made a significant contribution to the fabrication of complex architectures at the nanoscale. Their findings, published in the journal Advanced Functional Materials in March and featured as the journal’s back cover, introduced an innovative 3D nano...
    2024-04-11
  • Future Hospitals seminar to strengthen ties between ShanghaiTech and medical, industrial and scientific sectors in Switzerland
    On the afternoon of March 13, a collaborative seminar, jointly organized by ShanghaiTech, Shanghai Clinical Research and Trial Center, and Swissnex in China, was convened at the Conference Center of ShanghaiTech University. The seminar, with the theme of “Future Hospitals: Research Institutes Meet Industry”, brought together eminent representatives from sectors of medicine, science, and industry...
    2024-03-22
  • Mao Yijie is among the 2024 list of “Women in 6G”
    Recently, Assistant Professor Mao Yijie in the School of Information Science and Technology (SIST), successfully joined the list of “100 Brilliant and Inspiring Women in 6G” in 2024. The list was announced by the community “Women in 6G™”, aiming to recognize 100 women who have made outstanding contributions in the field of 6G telecom around the world.“Women in 6G™” is an international o...
    2024-03-06
  • A fast beamforming method for monitoring cavitation-based focused ultrasound therapies
    Microbubble cavitation-based focused ultrasound therapies can non-invasively open biological barriers temporarily, such as the blood-brain barrier and blood-tumor barrier. This emerging new type of therapy is undergoing a huge number of clinical investigations for drug delivery and for removing pathological tissues without opening the human body, and has great potential for the treatment of brain ...
    2024-02-08
  • Highly efficient tin-based tandem solar cells based on “surface freezing” strategy
    Perovskite is currently the most promising new type of solar cell material. Perovskite-based ultra-efficient solar cells have been rated as one of the “Top 10 Breakthrough Technologies of 2024” by MIT Technology Review. The commonly used lead perovskite solar cells have achieved high photoelectric conversion efficiency, but they still have shortcomings in terms of environmental friendliness and ...
    2024-02-04
  • ShanghaiTech wins 12 city-level honors for undergraduate teaching in 2023
     In recent years, ShanghaiTech University has continued to deepen the reform in education and teaching, to pay significant attention to the improvement of undergraduate education quality, and has made new progress in curriculum building and textbook compilation. In 2023, four ShanghaiTech courses joined the list of “First-class undergraduate courses in universities in Shanghai”, five course...
    2024-01-23
  • The world’s first clinical base editing therapy for hemoglobinopathy
    On January 8, 2024, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a  ShanghaiTech spinoff, using innovative transformer Base Editing (tBE) technology to help people with severe diseases, announced positive results of its base editing therapy for transfusion-dependent β-thalassemia, CS-101. As a collaboration with the First Affiliated Hospital of Guangxi Medical University, t...
    2024-01-10
  • The 6th ShanghaiTech Innovation & Entrepreneurship Summit concludes
    Year 2023 marks the 10th anniversary of ShanghaiTech University. As a connection between the past and future, ShanghaiTech Innovation & Entrepreneurship Summit (techIES) serves to welcome the university’s further development in the new decade. On December 22, 2023, the Carnival Event of the 6th techIES was held in the Conference Center, marking a successful conclusion of this year’s summit a...
    2024-01-09
  • SIST researchers develop the deep photonic reservoir computer
     The development of artificial intelligence relies, primarily, on deep neural networks, and the large-scale neural network language models like ChatGPT have posed great challenges to the electronic computing chips based on the von Neumann architecture. As a promising solution, optical computing can boost energy efficiency and reduce computation latency. In recent years, a large variety o...
    2024-01-08
  • SLST scientists establish mouse trophoblast organoids for the first time
    Through a 100-million-year evolution and adaptation, the eutherian placentae has become one ofthe most morphologically variable organs. Besides the fetal-maternal exchange, recent studies in mouse models have demonstrated that developmental defects in placentae could exert pronounced effects on embryo growth and development, leading to the necessity for high-throughput screens on modulators for mo...
    2023-12-22
  • Researchers reveal spatiotemporal multi-omics evolutionary map of liver cancer metastasis
    Hepatocellular carcinoma, a highly prevalent malignant tumor in China, accounts for nearly half of the newly diagnosed cases and deaths worldwide annually. Among liver cancer patients, 70-80% are diagnosed with tumor spread and metastasis, rendering them ineligible for surgical intervention. However, a comprehensive understanding of the molecular characteristics specific to metastatic liver cancer...
    2023-12-22
  • Explainable AI model for anti-cancer drug target discovery
    Associate Professor Zheng Jie’s lab in SIST has recently proposed an advanced artificial intelligence model named KR4SL. By integrating knowledge graphs and explainable graph neural networks, KR4SL has made strides in identifying anti-cancer drug targets based on synthetic lethality. This work has been formally published as a Proceedings paper in the top international bioinformatics conferen...
    2023-12-15